Holy Stone Healthcare Co., Ltd. 4194.TWO Stock
Holy Stone Healthcare Co., Ltd. Price Chart
Holy Stone Healthcare Co., Ltd. 4194.TWO Financial and Trading Overview
| Holy Stone Healthcare Co., Ltd. stock price | 17.8 TWD |
| Previous Close | 30.25 TWD |
| Open | 29.9 TWD |
| Bid | 29.8 TWD x 0 |
| Ask | 30 TWD x 0 |
| Day's Range | 29.8 - 30.1 TWD |
| 52 Week Range | 15.9 - 41.6 TWD |
| Volume | 180.83K TWD |
| Avg. Volume | 373.05K TWD |
| Market Cap | 4.15B TWD |
| Beta (5Y Monthly) | 1.567465 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -2.37 TWD |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
4194.TWO Valuation Measures
| Enterprise Value | 3.77B TWD |
| Trailing P/E | N/A |
| Forward P/E | N/A |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | 15.350134 |
| Price/Book (mrq) | 7.935244 |
| Enterprise Value/Revenue | 13.968 |
| Enterprise Value/EBITDA | -26.84 |
Trading Information
Holy Stone Healthcare Co., Ltd. Stock Price History
| Beta (5Y Monthly) | 1.567465 |
| 52-Week Change | 61.76% |
| S&P500 52-Week Change | 20.43% |
| 52 Week High | 41.6 TWD |
| 52 Week Low | 15.9 TWD |
| 50-Day Moving Average | 34.22 TWD |
| 200-Day Moving Average | 28.93 TWD |
4194.TWO Share Statistics
| Avg. Volume (3 month) | 373.05K TWD |
| Avg. Daily Volume (10-Days) | 163.39K TWD |
| Shares Outstanding | 138.74M |
| Float | N/A |
| Short Ratio | N/A |
| % Held by Insiders | N/A |
| % Held by Institutions | N/A |
| Shares Short | N/A |
| Short % of Float | N/A |
| Short % of Shares Outstanding | N/A |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0 |
| Last Split Factor |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | December 31, 2022 |
| Most Recent Quarter (mrq) | December 31, 2022 |
| Next Fiscal Year End | December 31, 2023 |
Profitability
| Profit Margin | -56.59% |
| Operating Margin (ttm) | -55.11% |
| Gross Margin | 45.61% |
| EBITDA Margin | -52.042% |
Management Effectiveness
| Return on Assets (ttm) | -19.44% |
| Return on Equity (ttm) | -38.87% |
Income Statement
| Revenue (ttm) | 270.24M TWD |
| Revenue Per Share (ttm) | 2.01 TWD |
| Quarterly Revenue Growth (yoy) | 28.49% |
| Gross Profit (ttm) | 123.28M TWD |
| EBITDA | -140640000 TWD |
| Net Income Avi to Common (ttm) | -152943008 TWD |
| Diluted EPS (ttm) | -1.16 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 445.23M TWD |
| Total Cash Per Share (mrq) | 3.21 TWD |
| Total Debt (mrq) | 23.24M TWD |
| Total Debt/Equity (mrq) | 4.45 TWD |
| Current Ratio (mrq) | 7.145 |
| Book Value Per Share (mrq) | 3.768 |
Cash Flow Statement
| Operating Cash Flow (ttm) | -145936000 TWD |
| Levered Free Cash Flow (ttm) | -87845000 TWD |
Profile of Holy Stone Healthcare Co., Ltd.
| Country | Taiwan |
| State | N/A |
| City | Taipei |
| Address | No. 88, Neihu Road |
| ZIP | 11493 |
| Phone | 886 2 8797 5966 |
| Website | https://www.hshc.com.tw |
| Industry | Biotechnology |
| Sector(s) | Healthcare |
| Full Time Employees | N/A |
Holy Stone Healthcare Co., Ltd. engages in the development of therapeutics in Taiwan. It offers RenehaVis, a product designed to relive pain and stiffness of the knee joint; SportVis, a treatment to relive the pain and optimize the recovery of tendon and ligament injuries; TRUD, a treatment that allows mucosal tissue to heal naturally and reduces the symptoms of ulcerative colitis; and GAF, a treatment for anal mucosal lesions. The company is also developing IBD98-M, which is in Phase IIa clinical trials for the treatment of inflammatory bowel diseases; and CA102N to treat colorectal cancer. In addition, it develops ND108E for the treatment of alzheimer's disease; and CA102L, a novel and small molecule conjugated therapeutic agent to treat lymphoma and multiple myeloma. The company was founded in 2001 and is headquartered in Taipei, Taiwan. Holy Stone Healthcare Co., Ltd. is a subsidiary of Holy Stone Enterprise Co.,Ltd.
Q&A For Holy Stone Healthcare Co., Ltd. Stock
What is a current 4194.TWO stock price?
Holy Stone Healthcare Co., Ltd. 4194.TWO stock price today per share is 17.8 TWD.
How to purchase Holy Stone Healthcare Co., Ltd. stock?
You can buy 4194.TWO shares on the Taipei Exchange exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Holy Stone Healthcare Co., Ltd.?
The stock symbol or ticker of Holy Stone Healthcare Co., Ltd. is 4194.TWO.
Which industry does the Holy Stone Healthcare Co., Ltd. company belong to?
The Holy Stone Healthcare Co., Ltd. industry is Biotechnology.
How many shares does Holy Stone Healthcare Co., Ltd. have in circulation?
The max supply of Holy Stone Healthcare Co., Ltd. shares is 124.29M.
What is Holy Stone Healthcare Co., Ltd. Price to Earnings Ratio (PE Ratio)?
Holy Stone Healthcare Co., Ltd. PE Ratio is now.
What was Holy Stone Healthcare Co., Ltd. earnings per share over the trailing 12 months (TTM)?
Holy Stone Healthcare Co., Ltd. EPS is -2.37 TWD over the trailing 12 months.
Which sector does the Holy Stone Healthcare Co., Ltd. company belong to?
The Holy Stone Healthcare Co., Ltd. sector is Healthcare.